ISSN:
1432-1076
Schlagwort(e):
High dose intravenous gammaglobulin therapy
;
Haemolytic disease of newborn
;
Rhesus incompatibility
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Medizin
Notizen:
Abstract A male neonate with hyperbilirubinaemia and progressing anaemia due to rhesus (c+E) incompatibility received high dose intravenous gammaglobulin (ivIgG) therapy at 13 days of age. Clinical response to therapy was confirmed by a rapid decrease in serum bilirubin level, and with the prevention of a further decline of the haemoglobin level. No side-effects were noted. High dose ivIgG therapy could be an alternative to (exchange) blood transfusion in case of some haemolytic diseases of newborn.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1007/BF01958434
Permalink